Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Aurobindo Pharma Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524804
ISIN Demat	INE406A01037
Book Value	353.55

NSE Code	AUROPHARMA
Dividend Yield %	0.00
Market Cap	691502.41

P/E	39.59
EPS	30.08
Face Value	1


	BSE		NSE

04-Jul-2025

Last Price	1190.60
Net Change	35.05
% Change	3.03%
Prev.Close	1155.55
Open	1157.05
High	1196.80
Low	1157.05
Volume	53082

Last Price	1191.30
Net Change	35.2
% Change	3.04%
Prev.Close	1156.10
Open	1160.10
High	1197.00
Low	1158.60
Volume	1933477

Value	62955649
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1196.80
52-Week High	1592.55
52-Week Low	994.35

Value	2288527575.4
Best Buy	1191.30
Best Sell	0.00
Best Quantity	641
Sell Quantity	0
Today's Range	1197.00
52-Week High	1592.00
52-Week Low	1010.00

Open Price	1169.30
High Price	1202.90
Low Price	1164.60
Last Price	1197.50
Prev Close	1163.60
Change	33.90
% Change	2.91 %

Average Price	1188.65
Underlying Value	1191.30
Number of contracts traded	7198
Turnover in Rs. Lakhs	47057
Open Interest	18810550.00
Change in O I	105600.00
% Change in O I	0.56 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	641
Price	1191.30

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	3300
Price	1196

Quantity	550
Price	1198

Holding Details

Latest Corporate Events

Bonus

1 : 1

20-Jul-15

Book Closure

23-Aug-23

25-Aug-23

Dividend

150 %

20-Feb-24

Company News

03-07-2025

Aurobindo Pharma’s arm ob...

03-07-2025

Aurobindo Pharma informs ...

30-06-2025

Aurobindo Pharma’s arm re...

30-06-2025

Aurobindo Pharma moves up...

25-06-2025

Aurobindo Pharma’s arm ob...

25-06-2025

Aurobindo Pharma surges a...

20-06-2025

Aurobindo Pharma submits ...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.